
Background: The small intestinal lamina propria (SiLP) serves as a reservoir for Th17 cells. Although increasing evidence linking intestinal Th17 cells to Rheumatoid Arthritis (RA), the immunological functions of small intestinal CD25 low Foxp3 + T cells and their connection to Th17 cell differentiation and RA pathogenesis remain poorly understood.
Objectives: This study aims to elucidate the immunological characteristics and functional roles of SiLP CD25 low Foxp3 + T cells and their pathogenic involvement in RA development.
Methods: We analyzed CD25 expression in Tregs isolated from PBMCs of RA patients and a mouse model of RA. Treg suppression assays and Th17 differentiation in vitro were conducted using sorted spleen CD25 high , CD25 low Foxp3 + T cell and SiLP CD25 low Foxp3 + T cells.
Results: In RA patients, the frequency of CD25 low Foxp3 + T cells was elevated in PBMCs compared to healthy individuals. In normal mice, among Foxp3 + Tregs from different tissues, CD25 low Foxp3 + T cells were particularly abundant in the small intestinal lamina propria (SiLP). Suppression assays conducted in vitro demonstrated comparable immunosuppressive abilities between spleen-derived CD25 high and CD25 low Foxp3 + T cells. However, SiLP CD25 low Foxp3 + T cells displayed diminished capacity to suppress CD4 + T cell proliferation when compared to their spleen-derived counterparts. Th17 differentiation experiments highlighted a higher propensity of SiLP CD25 low Foxp3 + T cells to adopt a Th17-like phenotype relative to spleen CD25 high Foxp3 + and CD25 low Foxp3 + T cells. Moreover, under Th17-skewing conditions, SiLP CD25 low Foxp3 + T cells produced significantly more IL-17A compared to spleen-derived Foxp3 + T cells.
Conclusion: Our results indicate that SiLP CD25 low Foxp3 + T cells contribute to disease pathogenesis. Gaining a more comprehensive understanding of these cells may shed light on the mechanisms driving Treg cell plasticity and pave the way for therapeutic strategies aimed at modulating their function.
REFERENCES: NIL.
Acknowledgements: NIL.
Disclosure of Interests: None declared.
© The Authors 2025. This abstract is an open access article published in Annals of Rheumatic Diseases under the CC BY-NC-ND license (